Literature DB >> 32647418

Experience of Immune Tolerance Induction Therapy for Hemophilia A Patients with Inhibitors from a Single Center in India.

Tulika Seth1.   

Abstract

The availability of clotting factor concentrates of both factor VIII and factor IX have improved hemophilia treatment to a great extent. Many more improvements like physiotherapy, and comprehensive care are needed to give better care. One important complication that occurs, but is often set aside is the development of inhibitors. When an inhibitor develops in a patient of severe hemophilia then the care becomes more difficult and expensive. Eradication of the inhibitor is possible by Immune tolerance induction (ITI), this paper explains some important essential factors and practical issues during my experience with ITI. © Indian Society of Hematology and Blood Transfusion 2019.

Entities:  

Keywords:  Eradication of inhibitors; Inherited hemophilia

Year:  2019        PMID: 32647418      PMCID: PMC7326901          DOI: 10.1007/s12288-019-01218-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  26 in total

Review 1.  Pearls and pitfalls in factor inhibitor assays.

Authors:  D M Adcock; E J Favaloro
Journal:  Int J Lab Hematol       Date:  2015-05       Impact factor: 2.877

2.  Extended half-life factor VIII for immune tolerance induction in haemophilia.

Authors:  L M Malec; J Journeycake; M V Ragni
Journal:  Haemophilia       Date:  2016-09-19       Impact factor: 4.287

Review 3.  Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

Authors:  C H Miller
Journal:  Haemophilia       Date:  2018-02-15       Impact factor: 4.287

4.  Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.

Authors:  E Berntorp; J Astermark; E Carlborg
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

5.  Factor VIII inhibitors in hemophilia A: rationale and latest evidence.

Authors:  Char Witmer; Guy Young
Journal:  Ther Adv Hematol       Date:  2013-02

Review 6.  The epidemiology of inhibitors in haemophilia A: a systematic review.

Authors:  J Wight; S Paisley
Journal:  Haemophilia       Date:  2003-07       Impact factor: 4.287

7.  When is enough…enough? Developing consensus of definition of failure of immune tolerance induction in patients with haemophilia and inhibitors.

Authors:  C Barnes; S A Brown; J Curtin; S Dunkley
Journal:  Haemophilia       Date:  2014-07       Impact factor: 4.287

Review 8.  New predictive approaches for ITI treatment.

Authors:  G D Minno; E Santagostino; K Pratt; C Königs
Journal:  Haemophilia       Date:  2014-09       Impact factor: 4.287

9.  Barriers and perceived limitations to early treatment of hemophilia.

Authors:  Kapil Saxena
Journal:  J Blood Med       Date:  2013-05-16

Review 10.  Epidemiology & social costs of haemophilia in India.

Authors:  Anita Kar; Supriya Phadnis; Sumedha Dharmarajan; Juhi Nakade
Journal:  Indian J Med Res       Date:  2014-07       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.